Worth reading
66In focus
Scored from 1 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
1220700
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Report on the exercise of the 7th Series Stock Acquisition Rights (with Exercise Price Adjustment Clause) (bulk exercise)
発行・処分する株式数
1,220,700 new shares (0 treasury shares transferred)
Amount of funds to be raised
Aggregate exercise amount of ¥381,095,720 (estimated net proceeds: Not disclosed)
Terms of the stock acquisition rights
Exercise price
¥297.0 (9 July) and ¥319.6 (13 July). Details of the adjustment clause and the adjustment floor: Not disclosed
Number of Stock Acquisition Rights
The total number issued was estimated at approximately 74,591 rights (calculated from the statement that 12,207 rights represented 16.37% of the total issued; not stated explicitly in the document). Rights exercised in this instance: 12,207; unexercised balance at the time of the previous disclosure: 46,391; current unexercised balance: 34,184
Most recent equity financing
Timing 30 March 2026 / Type Issuance of the 7th Series Stock Acquisition Rights with Exercise Price Adjustment Provisions / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Report on the exercise of the 7th Series Stock Acquisition Rights (with Exercise Price Adjustment Clause) (bulk exercise) |
| Number of shares to be issued or disposed of | 1,220,700 new shares (0 treasury shares transferred) |
| Amount of funds to be raised | Aggregate exercise amount of ¥381,095,720 (estimated net proceeds: Not disclosed) |
| Total number of issued shares | 31,278,000 shares (as of the end of the month preceding the relevant month) → Not disclosed |
| Exercise price | ¥297.0 (9 July) and ¥319.6 (13 July). Details of the adjustment clause and the adjustment floor: Not disclosed |
| Number of Stock Acquisition Rights | The total number issued was estimated at approximately 74,591 rights (calculated from the statement that 12,207 rights represented 16.37% of the total issued; not stated explicitly in the document). Rights exercised in this instance: 12,207; unexercised balance at the time of the previous disclosure: 46,391; current unexercised balance: 34,184 |
| Most recent equity financing | Timing 30 March 2026 / Type Issuance of the 7th Series Stock Acquisition Rights with Exercise Price Adjustment Provisions / Amount Not disclosed |
Items this document does not state (21)
Issue price and disposal priceTotal issue valueEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyDilution RateBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the bulk exercise of the 7th Series Stock Acquisition Rights during the period from 7 July to 13 July 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.